Log in

NASDAQ:IMVTImmunovant News Headlines

$25.58
+1.12 (+4.58 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$24.14
Now: $25.58
$25.79
50-Day Range
$18.77
MA: $24.56
$28.44
52-Week Range
$8.34
Now: $25.58
$29.96
Volume376,658 shs
Average Volume284,976 shs
Market Capitalization$2.09 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Immunovant (NASDAQ IMVT) News Headlines

Source:
DateHeadline
Analyzing Immunovant (IMVT) and The CompetitionAnalyzing Immunovant (IMVT) and The Competition
www.americanbankingnews.com - July 7 at 1:24 PM
Immunovant (IMVT) versus The Competition Critical AnalysisImmunovant (IMVT) versus The Competition Critical Analysis
www.americanbankingnews.com - July 7 at 9:26 AM
Contrasting Immunovant (IMVT) and Its CompetitorsContrasting Immunovant (IMVT) and Its Competitors
www.americanbankingnews.com - July 6 at 5:35 AM
Short Interest in Immunovant (NASDAQ:IMVT) Decreases By 57.4%Short Interest in Immunovant (NASDAQ:IMVT) Decreases By 57.4%
www.americanbankingnews.com - July 5 at 10:37 PM
Head to Head Comparison: Immunovant (IMVT) and Its PeersHead to Head Comparison: Immunovant (IMVT) and Its Peers
www.americanbankingnews.com - July 5 at 3:18 PM
Immunovant (IMVT) and Its Competitors Head-To-Head ReviewImmunovant (IMVT) and Its Competitors Head-To-Head Review
www.americanbankingnews.com - July 5 at 1:22 PM
Contrasting Immunovant (IMVT) and Its RivalsContrasting Immunovant (IMVT) and Its Rivals
www.americanbankingnews.com - July 5 at 3:10 AM
Reviewing Immunovant (IMVT) & Its RivalsReviewing Immunovant (IMVT) & Its Rivals
www.americanbankingnews.com - July 5 at 3:10 AM
Immunovant (IMVT) & Its Competitors Head-To-Head AnalysisImmunovant (IMVT) & Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - July 4 at 9:46 PM
Analyzing Immunovant (IMVT) & Its RivalsAnalyzing Immunovant (IMVT) & Its Rivals
www.americanbankingnews.com - July 4 at 1:16 PM
Contrasting Immunovant (IMVT) & Its CompetitorsContrasting Immunovant (IMVT) & Its Competitors
www.americanbankingnews.com - July 3 at 3:45 PM
Reviewing Immunovant (IMVT) & Its PeersReviewing Immunovant (IMVT) & Its Peers
www.americanbankingnews.com - July 3 at 1:49 PM
Immunovant (IMVT) & Its Rivals Head to Head ComparisonImmunovant (IMVT) & Its Rivals Head to Head Comparison
www.americanbankingnews.com - July 3 at 10:31 AM
Critical Contrast: Immunovant (IMVT) & Its CompetitorsCritical Contrast: Immunovant (IMVT) & Its Competitors
www.americanbankingnews.com - July 2 at 3:46 PM
Immunovant Forecasted to Post FY2021 Earnings of ($1.53) Per Share (NASDAQ:IMVT)Immunovant Forecasted to Post FY2021 Earnings of ($1.53) Per Share (NASDAQ:IMVT)
www.americanbankingnews.com - July 2 at 10:13 AM
SVB Leerink Weighs in on Immunovants Q1 2021 Earnings (NASDAQ:IMVT)SVB Leerink Weighs in on Immunovant's Q1 2021 Earnings (NASDAQ:IMVT)
www.americanbankingnews.com - July 2 at 9:41 AM
Analyzing Immunovant (IMVT) and Its RivalsAnalyzing Immunovant (IMVT) and Its Rivals
www.americanbankingnews.com - July 2 at 1:44 AM
Analyzing Immunovant (IMVT) and Its PeersAnalyzing Immunovant (IMVT) and Its Peers
www.americanbankingnews.com - July 1 at 1:53 PM
Analysts Offer Predictions for Immunovants Q1 2021 Earnings (NASDAQ:IMVT)Analysts Offer Predictions for Immunovant's Q1 2021 Earnings (NASDAQ:IMVT)
www.americanbankingnews.com - July 1 at 9:42 AM
Reviewing Immunovant (IMVT) & The CompetitionReviewing Immunovant (IMVT) & The Competition
www.americanbankingnews.com - July 1 at 8:28 AM
Immunovant (NASDAQ:IMVT) Releases  Earnings ResultsImmunovant (NASDAQ:IMVT) Releases Earnings Results
www.americanbankingnews.com - June 30 at 7:07 AM
Immunovant EPS beats by $0.20Immunovant EPS beats by $0.20
seekingalpha.com - June 29 at 12:49 PM
Immunovant Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2020 and Announces Plans for Phase 3 Registrational Trial of IMVT-1401 in Myasthenia GravisImmunovant Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2020 and Announces Plans for Phase 3 Registrational Trial of IMVT-1401 in Myasthenia Gravis
finance.yahoo.com - June 29 at 7:49 AM
Immunovant (NASDAQ:IMVT) Short Interest Down 24.3% in JuneImmunovant (NASDAQ:IMVT) Short Interest Down 24.3% in June
www.americanbankingnews.com - June 19 at 6:03 PM
Immunovant (NASDAQ:IMVT) Stock Rating Upgraded by SunTrust BanksImmunovant (NASDAQ:IMVT) Stock Rating Upgraded by SunTrust Banks
www.americanbankingnews.com - June 18 at 6:05 AM
SunTrust Banks Boosts Immunovant (NASDAQ:IMVT) Price Target to $36.00SunTrust Banks Boosts Immunovant (NASDAQ:IMVT) Price Target to $36.00
www.americanbankingnews.com - June 17 at 3:41 PM
Immunovant (NASDAQ:IMVT) Receives Average Rating of "Buy" from AnalystsImmunovant (NASDAQ:IMVT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - June 16 at 3:41 AM
Why Immunovant (IMVT) Stock Might be a Great PickWhy Immunovant (IMVT) Stock Might be a Great Pick
www.nasdaq.com - June 11 at 12:55 PM
Will Immunovant Continue to Surge Higher?Will Immunovant Continue to Surge Higher?
www.nasdaq.com - June 8 at 1:14 PM
IMVT Immunovant, Inc. Common StockIMVT Immunovant, Inc. Common Stock
www.nasdaq.com - May 20 at 12:02 PM
Which way to trade Immunovant Inc (NAQ:IMVT)?Which way to trade Immunovant Inc (NAQ:IMVT)?
uk.finance.yahoo.com - May 13 at 7:53 AM
Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters Option to Purchase Additional SharesImmunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
www.benzinga.com - April 16 at 6:48 PM
Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesImmunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 16 at 6:48 PM
Immunovant prices stock offering at $14.50Immunovant prices stock offering at $14.50
seekingalpha.com - April 14 at 2:20 PM
Immunovant Announces Pricing of $121.2 Million Public OfferingImmunovant Announces Pricing of $121.2 Million Public Offering
finance.yahoo.com - April 14 at 2:20 PM
Immunovant files for equity offeringImmunovant files for equity offering
seekingalpha.com - April 10 at 12:29 PM
AMRNs Vascepa Woes, AKRO Awaits Big Day, JNJs COVID-19 Vaccine Study In Sep AMRN's Vascepa Woes, AKRO Awaits Big Day, JNJ's COVID-19 Vaccine Study In Sep
www.rttnews.com - March 31 at 2:52 AM
Stock Alert: Immunovant Spikes On Results Of Its IMVT-1401Stock Alert: Immunovant Spikes On Results Of Its IMVT-1401
www.nasdaq.com - March 30 at 4:57 PM
Immunovant Announces Positive Clinical Results...Immunovant Announces Positive Clinical Results...
www.benzinga.com - March 30 at 8:41 AM
Immunovant +4% premarket on positive IMVT-1401 dataImmunovant +4% premarket on positive IMVT-1401 data
seekingalpha.com - March 30 at 8:41 AM
Immunovant Announces Positive Clinical Results from Ongoing Phase 2a Proof-of-Concept Study of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Thyroid Eye DiseaseImmunovant Announces Positive Clinical Results from Ongoing Phase 2a Proof-of-Concept Study of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Thyroid Eye Disease
finance.yahoo.com - March 30 at 8:41 AM
Heres Why Immunovant (IMVT) Merits A Look Here's Why Immunovant (IMVT) Merits A Look
www.rttnews.com - March 10 at 5:18 AM
This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.